Keyword |
Issue |
Title |
Abdominal pain |
2023;57(2):132-137 |
Unusual biclonal IgA plasma cell myeloma with aberrant expression of high-risk immunophenotypes: first report of a new diagnostic and clinical challenge |
Active surveillance |
2023;57(6):289-304 |
The Asian Thyroid Working Group, from 2017 to 2023 |
Acute respiratory distress syndrome |
2022;56(2):81-91 |
Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injury |
Adenocarcinoma |
2022;56(2):63-72 |
Extremely well-differentiated adenocarcinoma of the stomach: diagnostic pitfalls in endoscopic biopsy |
Adenocarcinoma of lung |
2022;56(6):334-341 |
Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea |
Adrenal gland |
2022;56(1):32-39 |
Clinicopathologic implication of PD-L1 gene alteration in primary adrenal diffuse large B cell lymphoma |
Adrenal glands |
2022;56(3):161-166 |
Adrenal hemangioblastoma |
Adult |
2022;56(3):152-156 |
A sinonasal yolk sac tumor in an adult |
Alpha fetoprotein |
2022;56(2):97-102 |
Colorectal adenocarcinoma with enteroblastic differentiation: diagnostic challenges of a rare case encountered in clinical practice |
Anaplastic large cell lymphoma |
2023;57(1):75-78 |
Metallic implant-associated lymphoma: ALK-negative anaplastic large cell lymphoma associated with total knee replacement arthroplasty |
Anaplastic lymphoma kinase |
2022;56(4):231-237 |
Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review |
Aneurysmal bone cyst |
2023;57(2):81-87 |
Aneurysmal bone cyst: a review |
Apocrine changes |
2023;57(3):158-165 |
Frequent apocrine changes in pleomorphic adenoma with malignant transformation: a possible pre-malignant step in ductal carcinoma ex pleomorphic adenoma |
Aquaporin |
2023;57(4):232-237 |
Loss of aquaporin-1 expression is associated with worse clinical outcomes in clear cell renal cell carcinoma: an immunohistochemical study |
Asia |
2023;57(6):289-304 |
The Asian Thyroid Working Group, from 2017 to 2023 |
Atrophy |
2023;57(3):139-146 |
Trouble-makers in cytologic interpretation of the uterine cervix |
Atypical pleomorphic adenoma |
2023;57(3):158-165 |
Frequent apocrine changes in pleomorphic adenoma with malignant transformation: a possible pre-malignant step in ductal carcinoma ex pleomorphic adenoma |
Autopsy |
2023;57(2):123-127 |
Unsuspected systemic Epstein-Barr virus–positive T-cell lymphoma of childhood diagnosed at autopsy in a potential homicide case |
2022;56(4):217-224 |
Clinically undetected plasmacytoid urothelial carcinoma of the urinary bladder with non-mass-forming metastases in multiple organs: an autopsy case |
Axin2 |
2023;57(6):315-322 |
Elevated expression of Axin2 in intestinal metaplasia and gastric cancers |
Betacoronavirus |
2023;57(2):102-112 |
Postmortem lung and heart examination of COVID-19 patients in a case series from Jordan |
Biclonal IgA |
2023;57(2):132-137 |
Unusual biclonal IgA plasma cell myeloma with aberrant expression of high-risk immunophenotypes: first report of a new diagnostic and clinical challenge |
Biomarker |
2023;57(3):147-157 |
Expression of specific microRNAs in tissue and plasma in colorectal cancer |
2022;56(1):40-47 |
Polo-like kinase 4 as a potential predictive biomarker of chemoradioresistance in locally advanced rectal cancer |
Biomarkers |
2022;56(6):326-333 |
Biomarker testing of cytology specimens in personalized medicine for lung cancer patients |
Biopsy |
2023;57(5):278-283 |
Diagnostic conundrums of schwannomas: two cases highlighting morphological extremes and diagnostic challenges in biopsy specimens of soft tissue tumors |
Biopsy, Core needle |
2023;57(4):208-216 |
Reevaluating diagnostic categories and associated malignancy risks in thyroid core needle biopsy |
Bladder urothelial carcinoma |
2023;57(2):88-94 |
Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma |
Bleomycin |
2022;56(2):81-91 |
Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injury |
Body fluid |
2022;56(4):173-186 |
Lymphoproliferative disorder involving body fluid: diagnostic approaches and roles of ancillary studies |
Bone cyst |
2023;57(2):81-87 |
Aneurysmal bone cyst: a review |
Brain |
2022;56(3):115-125 |
Neuropathologic features of central nervous system hemangioblastoma |
Brain metastases |
2023;57(4):217-231 |
Single-center study on clinicopathological and typical molecular pathologic features of metastatic brain tumor |
BRCA1 |
2022;56(4):212-216 |
Founder BRCA1 mutations in Nepalese population |
BRCA2 |
2022;56(4):212-216 |
Founder BRCA1 mutations in Nepalese population |
Breast angiosarcoma |
2022;56(6):342-353 |
A clinicopathologic and immunohistochemical study of primary and secondary breast angiosarcoma |
Breast neoplasms |
2023;57(4):238-241 |
Metastatic choroidal melanoma in the breast: a case report and review of the literature |
BRG1 |
2022;56(1):53-56 |
TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma |
Calprotectin |
2022;56(5):239-248 |
Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn’s disease: image processing and analysis study |
Calretinin |
2022;56(5):239-248 |
Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn’s disease: image processing and analysis study |
Cancer biomarker |
2022;56(6):309-318 |
The application of high-throughput proteomics in cytopathology |
Cancer of unknown primary |
2022;56(4):217-224 |
Clinically undetected plasmacytoid urothelial carcinoma of the urinary bladder with non-mass-forming metastases in multiple organs: an autopsy case |
Carcinoma |
2023;57(1):67-74 |
The proteomic landscape shows oncologic relevance in cystitis glandularis |
2022;56(4):225-230 |
Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature |
Carcinoma ex pleomorphic adenoma |
2023;57(3):158-165 |
Frequent apocrine changes in pleomorphic adenoma with malignant transformation: a possible pre-malignant step in ductal carcinoma ex pleomorphic adenoma |
Cavernous hemangioma |
2022;56(1):16-21 |
Clinicopathological differences in radiation-induced organizing hematomas of the brain based on type of radiation treatment and primary lesions |
Cellular senescence |
2023;57(6):305-314 |
Senescent tumor cells in colorectal cancer are characterized by elevated enzymatic activity of complexes 1 and 2 in oxidative phosphorylation |
Cerebellar neoplasms |
2022;56(3):115-125 |
Neuropathologic features of central nervous system hemangioblastoma |
Cervical intraepithelial neoplasia |
2022;56(5):289-293 |
Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection |
Cervix uteri |
2022;56(5):260-269 |
Cytopathologic features of human papillomavirus–independent, gastric-type endocervical adenocarcinoma |
Chemoradiotherapy |
2022;56(1):40-47 |
Polo-like kinase 4 as a potential predictive biomarker of chemoradioresistance in locally advanced rectal cancer |
Chondromyxoid fibroma |
2022;56(3):157-160 |
Juxtacortical chondromyxoid fibroma in the small bones: two cases with unusual location and a literature review |
Chromosomal instability |
2023;57(6):323-331 |
BRCA-mutated gastric adenocarcinomas are associated with chromosomal instability and responsiveness to platinum-based chemotherapy |
Chronic lymphocytic leukemia |
2022;56(1):48-52 |
Chronic lymphocytic leukemia and concurrent seminoma in the same testis |
Cirrhosis |
2023;57(4):189-195 |
A review of liver fibrosis and cirrhosis regression |
Clear cell renal cell carcinoma |
2023;57(4):232-237 |
Loss of aquaporin-1 expression is associated with worse clinical outcomes in clear cell renal cell carcinoma: an immunohistochemical study |
Clinical pathology |
2023;57(4):217-231 |
Single-center study on clinicopathological and typical molecular pathologic features of metastatic brain tumor |
Colitis |
2023;57(1):60-66 |
Inflammatory bowel disease–associated intestinal fibrosis |
Colorectal adenocarcinoma with enteroblastic differentiation |
2022;56(2):97-102 |
Colorectal adenocarcinoma with enteroblastic differentiation: diagnostic challenges of a rare case encountered in clinical practice |
Colorectal neoplasm |
2023;57(3):147-157 |
Expression of specific microRNAs in tissue and plasma in colorectal cancer |
Colorectal neoplasms |
2023;57(6):305-314 |
Senescent tumor cells in colorectal cancer are characterized by elevated enzymatic activity of complexes 1 and 2 in oxidative phosphorylation |
2022;56(3):144-151 |
Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis |
2022;56(2):97-102 |
Colorectal adenocarcinoma with enteroblastic differentiation: diagnostic challenges of a rare case encountered in clinical practice |
Composite lymphoma |
2022;56(1):57-60 |
Composite follicular lymphoma and classic Hodgkin lymphoma |
Concurrent tumor |
2022;56(1):48-52 |
Chronic lymphocytic leukemia and concurrent seminoma in the same testis |
Conjunctival melanoma |
2022;56(4):187-198 |
Clinicopathologic features and survival outcomes of ocular melanoma: a series of 31 cases from a tertiary university hospital |
Coronavirus |
2022;56(6):361-369 |
Current status of cytopathology practice in Korea: impact of the coronavirus pandemic on cytopathology practice |
COVID-19 |
2023;57(1):28-42 |
Infections and immunity: associations with obesity and related metabolic disorders |
Cowden |
2023;57(3):178-183 |
Thyroid pathology, a clue to PTEN hamartoma tumor syndrome |
Crizotinib |
2022;56(4):231-237 |
Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review |
Crohn disease |
2023;57(1):60-66 |
Inflammatory bowel disease–associated intestinal fibrosis |
Crohn’s disease |
2022;56(5):239-248 |
Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn’s disease: image processing and analysis study |
Cystitis |
2023;57(1):67-74 |
The proteomic landscape shows oncologic relevance in cystitis glandularis |
Cytogenetics |
2022;56(1):1-15 |
Follicular lymphoma: updates for pathologists |
Cytology |
2023;57(5):251-264 |
Diagnostic proficiency test using digital cytopathology and comparative assessment of whole slide images of cytologic samples for quality assurance program in Korea |
2023;57(4):196-207 |
A stepwise approach to fine needle aspiration cytology of lymph nodes |
2023;57(3):139-146 |
Trouble-makers in cytologic interpretation of the uterine cervix |
2022;56(6):361-369 |
Current status of cytopathology practice in Korea: impact of the coronavirus pandemic on cytopathology practice |
2022;56(6):309-318 |
The application of high-throughput proteomics in cytopathology |
2022;56(6):326-333 |
Biomarker testing of cytology specimens in personalized medicine for lung cancer patients |
2022;56(5):260-269 |
Cytopathologic features of human papillomavirus–independent, gastric-type endocervical adenocarcinoma |
2022;56(4):173-186 |
Lymphoproliferative disorder involving body fluid: diagnostic approaches and roles of ancillary studies |
Cytopathology |
2023;57(2):95-101 |
Current state of cytopathology residency training: a Korean national survey of pathologists |
2022;56(6):354-360 |
Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology: a 25-year single-center study |
Deep sequencing |
2022;56(5):249-259 |
Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing |
Deficient mismatch repair |
2022;56(2):92-96 |
An unusual case of microsatellite instability–high/deficient mismatch repair (MSI-H/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing |
Diagnosis |
2023;57(4):196-207 |
A stepwise approach to fine needle aspiration cytology of lymph nodes |
Diagnostic criteria |
2023;57(6):289-304 |
The Asian Thyroid Working Group, from 2017 to 2023 |
Diffuse alveolar damage |
2023;57(2):102-112 |
Postmortem lung and heart examination of COVID-19 patients in a case series from Jordan |
Diffuse large B cell lymphoma |
2022;56(1):32-39 |
Clinicopathologic implication of PD-L1 gene alteration in primary adrenal diffuse large B cell lymphoma |
Diffuse large B-cell lymphoma |
2022;56(2):92-96 |
An unusual case of microsatellite instability–high/deficient mismatch repair (MSI-H/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing |
Digital pathology |
2023;57(5):251-264 |
Diagnostic proficiency test using digital cytopathology and comparative assessment of whole slide images of cytologic samples for quality assurance program in Korea |
2022;56(6):370-382 |
Development of quality assurance program for digital pathology by the Korean Society of Pathologists |
Diseases |
2023;57(1):43-51 |
Single-cell and spatial sequencing application in pathology |
DLL4 |
2023;57(2):113-122 |
Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer |
Duodenum |
2023;57(2):128-131 |
Solitary Peutz-Jeghers type harmartomatous polyp in duodenum with gastric foveolar epithelium: a case report |
Early detection of cancer |
2022;56(6):354-360 |
Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology: a 25-year single-center study |
Education |
2023;57(2):95-101 |
Current state of cytopathology residency training: a Korean national survey of pathologists |
EGFL7 |
2022;56(4):205-211 |
EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome |
Endodermal sinus tumor |
2022;56(3):152-156 |
A sinonasal yolk sac tumor in an adult |
Endoscopic resection |
2023;57(1):1-27 |
A standardized pathology report for gastric cancer: 2nd edition |
Epidermal growth factor receptor |
2022;56(5):249-259 |
Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing |
Epithelioid inflammatory myofibroblastic sarcoma |
2022;56(4):231-237 |
Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review |
Epstein-Barr virus |
2023;57(6):332-336 |
Intravascular NK/T-cell lymphoma: a case report and literature review |
Epstein-Barr virus infections |
2023;57(3):166-177 |
Clinicopathologic characterization of cervical metastasis from an unknown primary tumor: a multicenter study in Korea |
2023;57(2):123-127 |
Unsuspected systemic Epstein-Barr virus–positive T-cell lymphoma of childhood diagnosed at autopsy in a potential homicide case |
EWSR1 gene rearrangement |
2023;57(5):284-288 |
EWSR1 rearranged primary renal myoepithelial carcinoma: a diagnostic conundrum |
Extranodal NK-T-cell lymphoma |
2023;57(6):332-336 |
Intravascular NK/T-cell lymphoma: a case report and literature review |
Extremities |
2023;57(5):278-283 |
Diagnostic conundrums of schwannomas: two cases highlighting morphological extremes and diagnostic challenges in biopsy specimens of soft tissue tumors |
FASN |
2022;56(2):73-80 |
Fatty acid synthetase expression in triple-negative breast cancer |
Fibrosis |
2023;57(4):189-195 |
A review of liver fibrosis and cirrhosis regression |
2023;57(1):60-66 |
Inflammatory bowel disease–associated intestinal fibrosis |
2022;56(5):239-248 |
Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn’s disease: image processing and analysis study |
2022;56(2):81-91 |
Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injury |
Fine needle aspiration |
2023;57(4):196-207 |
A stepwise approach to fine needle aspiration cytology of lymph nodes |
Fine needle aspiration (FNA) |
2023;57(6):289-304 |
The Asian Thyroid Working Group, from 2017 to 2023 |
Fine-needle aspiration |
2022;56(6):309-318 |
The application of high-throughput proteomics in cytopathology |
Fine-needle aspiration cytology |
2022;56(6):319-325 |
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: its updated diagnostic criteria, preoperative cytologic diagnoses and impact on the risk of malignancy |
2022;56(5):301-308 |
Papillary and medullary thyroid carcinomas coexisting in the same lobe, first suspected based on fine-needle aspiration cytology: a case report |
Fluorescence in situ hybridization |
2022;56(4):231-237 |
Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review |
Follicular lymphoma |
2022;56(1):1-15 |
Follicular lymphoma: updates for pathologists |
2022;56(1):57-60 |
Composite follicular lymphoma and classic Hodgkin lymphoma |
Forensic medicine |
2023;57(2):102-112 |
Postmortem lung and heart examination of COVID-19 patients in a case series from Jordan |
Founder mutation |
2022;56(4):212-216 |
Founder BRCA1 mutations in Nepalese population |
Frozen sections |
2023;57(5):278-283 |
Diagnostic conundrums of schwannomas: two cases highlighting morphological extremes and diagnostic challenges in biopsy specimens of soft tissue tumors |
Fusobacteria |
2022;56(3):144-151 |
Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis |
Gallbladder neoplasms |
2023;57(2):113-122 |
Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer |
Gamma knife surgery |
2022;56(1):16-21 |
Clinicopathological differences in radiation-induced organizing hematomas of the brain based on type of radiation treatment and primary lesions |
Gastrectomy |
2023;57(1):1-27 |
A standardized pathology report for gastric cancer: 2nd edition |
Gastric carcinoma |
2023;57(6):315-322 |
Elevated expression of Axin2 in intestinal metaplasia and gastric cancers |
Gastric mucosa |
2023;57(2):128-131 |
Solitary Peutz-Jeghers type harmartomatous polyp in duodenum with gastric foveolar epithelium: a case report |
Gastric neoplasms |
2023;57(6):323-331 |
BRCA-mutated gastric adenocarcinomas are associated with chromosomal instability and responsiveness to platinum-based chemotherapy |
Gastric type adenocarcinoma |
2022;56(5):260-269 |
Cytopathologic features of human papillomavirus–independent, gastric-type endocervical adenocarcinoma |
gene |
2023;57(2):81-87 |
Aneurysmal bone cyst: a review |
Genes, BRCA2 |
2023;57(6):323-331 |
BRCA-mutated gastric adenocarcinomas are associated with chromosomal instability and responsiveness to platinum-based chemotherapy |
Glandular and epithelial neoplasms |
2022;56(6):354-360 |
Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology: a 25-year single-center study |
Glandular involvement |
2023;57(3):139-146 |
Trouble-makers in cytologic interpretation of the uterine cervix |
Glioblastoma IDH-wildtype |
2022;56(4):205-211 |
EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome |
Goiter |
2023;57(4):242-245 |
Intrathyroidal metastasis of tonsillar squamous cell carcinoma masquerading as a primary thyroid tumor |
Hamartoma |
2023;57(2):128-131 |
Solitary Peutz-Jeghers type harmartomatous polyp in duodenum with gastric foveolar epithelium: a case report |
Hamartoma tumor syndrome |
2023;57(3):178-183 |
Thyroid pathology, a clue to PTEN hamartoma tumor syndrome |
Head and neck squamous cell carcinoma |
2022;56(3):126-133 |
Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand |
Hemangioblastoma |
2022;56(3):161-166 |
Adrenal hemangioblastoma |
2022;56(3):115-125 |
Neuropathologic features of central nervous system hemangioblastoma |
Hepatic small vessel neoplasm |
2023;57(5):273-277 |
Hepatic small vessel neoplasm: not totally benign, not yet malignant |
Heterotopic |
2022;56(5):294-300 |
Heterotopic mesenteric ossification: a report of two cases |
HIF2α |
2023;57(2):113-122 |
Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer |
High grade intraepithelial squamous lesion |
2023;57(3):139-146 |
Trouble-makers in cytologic interpretation of the uterine cervix |
High-risk phenotypes |
2023;57(2):132-137 |
Unusual biclonal IgA plasma cell myeloma with aberrant expression of high-risk immunophenotypes: first report of a new diagnostic and clinical challenge |
Histology |
2023;57(1):43-51 |
Single-cell and spatial sequencing application in pathology |
Histopathology |
2022;56(4):187-198 |
Clinicopathologic features and survival outcomes of ocular melanoma: a series of 31 cases from a tertiary university hospital |
Hodgkin lymphoma |
2022;56(1):57-60 |
Composite follicular lymphoma and classic Hodgkin lymphoma |
Homicide |
2023;57(2):123-127 |
Unsuspected systemic Epstein-Barr virus–positive T-cell lymphoma of childhood diagnosed at autopsy in a potential homicide case |
Homologous recombination |
2023;57(6):323-331 |
BRCA-mutated gastric adenocarcinomas are associated with chromosomal instability and responsiveness to platinum-based chemotherapy |
Human papillomavirus virus |
2023;57(3):166-177 |
Clinicopathologic characterization of cervical metastasis from an unknown primary tumor: a multicenter study in Korea |
Hypopharyngeal carcinoma |
2022;56(3):126-133 |
Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand |
Immune cells |
2023;57(1):28-42 |
Infections and immunity: associations with obesity and related metabolic disorders |
Immunocytochemistry |
2022;56(4):173-186 |
Lymphoproliferative disorder involving body fluid: diagnostic approaches and roles of ancillary studies |
Immunohistochemistry |
2023;57(5):278-283 |
Diagnostic conundrums of schwannomas: two cases highlighting morphological extremes and diagnostic challenges in biopsy specimens of soft tissue tumors |
2023;57(4):232-237 |
Loss of aquaporin-1 expression is associated with worse clinical outcomes in clear cell renal cell carcinoma: an immunohistochemical study |
2022;56(6):334-341 |
Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea |
2022;56(6):342-353 |
A clinicopathologic and immunohistochemical study of primary and secondary breast angiosarcoma |
2022;56(5):270-280 |
Special AT-rich sequence-binding protein 2 (SATB2) in the differential diagnosis of osteogenic and non-osteogenic bone and soft tissue tumors |
2022;56(5):281-288 |
Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma |
2022;56(4):225-230 |
Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature |
2022;56(3):161-166 |
Adrenal hemangioblastoma |
2022;56(3):134-143 |
Expression of prostate-specific membrane antigen in the neovasculature of primary tumors and lymph node metastasis of laryngeal squamous cell carcinomas |
2022;56(2):73-80 |
Fatty acid synthetase expression in triple-negative breast cancer |
2022;56(2):103-108 |
Recurrent malignant solitary fibrous tumor of the scalp: a case report and literature review |
2022;56(1):1-15 |
Follicular lymphoma: updates for pathologists |
Infections |
2023;57(1):28-42 |
Infections and immunity: associations with obesity and related metabolic disorders |
Inflammatory bowel disease |
2023;57(1):60-66 |
Inflammatory bowel disease–associated intestinal fibrosis |
Inflammatory myofibroblastic tumor |
2022;56(4):231-237 |
Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review |
Inhibin |
2022;56(4):225-230 |
Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature |
Intestinal metaplasia |
2023;57(6):315-322 |
Elevated expression of Axin2 in intestinal metaplasia and gastric cancers |
Intestinal polyps |
2023;57(2):128-131 |
Solitary Peutz-Jeghers type harmartomatous polyp in duodenum with gastric foveolar epithelium: a case report |
Intrathyroidal metastasis |
2023;57(4):242-245 |
Intrathyroidal metastasis of tonsillar squamous cell carcinoma masquerading as a primary thyroid tumor |
Invasiveness |
2022;56(1):22-31 |
Association of PTTG1 expression with invasiveness of non-functioning pituitary adenomas |
Juxtacortical |
2022;56(3):157-160 |
Juxtacortical chondromyxoid fibroma in the small bones: two cases with unusual location and a literature review |
Ki-67 |
2022;56(2):73-80 |
Fatty acid synthetase expression in triple-negative breast cancer |
Kidney |
2023;57(5):284-288 |
EWSR1 rearranged primary renal myoepithelial carcinoma: a diagnostic conundrum |
Knee |
2023;57(1):75-78 |
Metallic implant-associated lymphoma: ALK-negative anaplastic large cell lymphoma associated with total knee replacement arthroplasty |
large B-cell lymphoma |
2022;56(5):281-288 |
Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma |
Larynx |
2022;56(3):134-143 |
Expression of prostate-specific membrane antigen in the neovasculature of primary tumors and lymph node metastasis of laryngeal squamous cell carcinomas |
Latency |
2022;56(1):16-21 |
Clinicopathological differences in radiation-induced organizing hematomas of the brain based on type of radiation treatment and primary lesions |
Liquid biopsy |
2023;57(3):147-157 |
Expression of specific microRNAs in tissue and plasma in colorectal cancer |
Liver |
2023;57(5):273-277 |
Hepatic small vessel neoplasm: not totally benign, not yet malignant |
2023;57(4):189-195 |
A review of liver fibrosis and cirrhosis regression |
2022;56(4):225-230 |
Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature |
Lung |
2022;56(4):231-237 |
Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review |
2022;56(1):53-56 |
TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma |
Lung adenocarcinoma |
2022;56(5):249-259 |
Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing |
Lung neoplasms |
2022;56(6):326-333 |
Biomarker testing of cytology specimens in personalized medicine for lung cancer patients |
Lymph node |
2023;57(4):196-207 |
A stepwise approach to fine needle aspiration cytology of lymph nodes |
Lymph node metastasis |
2023;57(3):166-177 |
Clinicopathologic characterization of cervical metastasis from an unknown primary tumor: a multicenter study in Korea |
2022;56(4):199-204 |
Correlation between myoferlin expression and lymph node metastasis in papillary thyroid carcinoma |
Lymph nodes |
2022;56(3):134-143 |
Expression of prostate-specific membrane antigen in the neovasculature of primary tumors and lymph node metastasis of laryngeal squamous cell carcinomas |
Lymphoid neoplasms |
2023;57(4):196-207 |
A stepwise approach to fine needle aspiration cytology of lymph nodes |
Lymphoma |
2023;57(2):123-127 |
Unsuspected systemic Epstein-Barr virus–positive T-cell lymphoma of childhood diagnosed at autopsy in a potential homicide case |
Lymphoproliferative disorder |
2022;56(4):173-186 |
Lymphoproliferative disorder involving body fluid: diagnostic approaches and roles of ancillary studies |
Malignant lymphoma |
2023;57(6):332-336 |
Intravascular NK/T-cell lymphoma: a case report and literature review |
2022;56(4):173-186 |
Lymphoproliferative disorder involving body fluid: diagnostic approaches and roles of ancillary studies |
2022;56(1):32-39 |
Clinicopathologic implication of PD-L1 gene alteration in primary adrenal diffuse large B cell lymphoma |
Mass spectrometry |
2022;56(6):309-318 |
The application of high-throughput proteomics in cytopathology |
Medullary thyroid carcinoma |
2022;56(5):301-308 |
Papillary and medullary thyroid carcinomas coexisting in the same lobe, first suspected based on fine-needle aspiration cytology: a case report |
Mesentery |
2022;56(5):294-300 |
Heterotopic mesenteric ossification: a report of two cases |
Metabolic disorders |
2023;57(1):28-42 |
Infections and immunity: associations with obesity and related metabolic disorders |
Metabolism |
2023;57(6):305-314 |
Senescent tumor cells in colorectal cancer are characterized by elevated enzymatic activity of complexes 1 and 2 in oxidative phosphorylation |
Metaplasia |
2023;57(3):139-146 |
Trouble-makers in cytologic interpretation of the uterine cervix |
Metastasis |
2023;57(4):238-241 |
Metastatic choroidal melanoma in the breast: a case report and review of the literature |
Microsatellite instability |
2022;56(2):92-96 |
An unusual case of microsatellite instability–high/deficient mismatch repair (MSI-H/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing |
mircroRNA |
2023;57(3):147-157 |
Expression of specific microRNAs in tissue and plasma in colorectal cancer |
Missed diagnosis |
2022;56(2):63-72 |
Extremely well-differentiated adenocarcinoma of the stomach: diagnostic pitfalls in endoscopic biopsy |
Mitosis |
2023;57(5):278-283 |
Diagnostic conundrums of schwannomas: two cases highlighting morphological extremes and diagnostic challenges in biopsy specimens of soft tissue tumors |
Molecular |
2022;56(1):1-15 |
Follicular lymphoma: updates for pathologists |
Molecular pathology |
2023;57(5):265-272 |
Establishing molecular pathology curriculum for pathology trainees and continued medical education: a collaborative work from the Molecular Pathology Study Group of the Korean Society of Pathologists |
2023;57(4):217-231 |
Single-center study on clinicopathological and typical molecular pathologic features of metastatic brain tumor |
2023;57(1):1-27 |
A standardized pathology report for gastric cancer: 2nd edition |
Molecular testing |
2022;56(6):326-333 |
Biomarker testing of cytology specimens in personalized medicine for lung cancer patients |
Multiple HPV infection |
2022;56(5):289-293 |
Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection |
Mutation |
2023;57(4):208-216 |
Reevaluating diagnostic categories and associated malignancy risks in thyroid core needle biopsy |
mutations |
2022;56(3):126-133 |
Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand |
Myoepithelial carcinoma |
2023;57(5):284-288 |
EWSR1 rearranged primary renal myoepithelial carcinoma: a diagnostic conundrum |
Myoferlin |
2022;56(4):199-204 |
Correlation between myoferlin expression and lymph node metastasis in papillary thyroid carcinoma |
NADH |
2023;57(6):305-314 |
Senescent tumor cells in colorectal cancer are characterized by elevated enzymatic activity of complexes 1 and 2 in oxidative phosphorylation |
Nasal cavity |
2022;56(3):152-156 |
A sinonasal yolk sac tumor in an adult |
Neovascularization |
2022;56(3):134-143 |
Expression of prostate-specific membrane antigen in the neovasculature of primary tumors and lymph node metastasis of laryngeal squamous cell carcinomas |
Nepal |
2022;56(4):212-216 |
Founder BRCA1 mutations in Nepalese population |
Neurilemmoma |
2023;57(5):278-283 |
Diagnostic conundrums of schwannomas: two cases highlighting morphological extremes and diagnostic challenges in biopsy specimens of soft tissue tumors |
Neuropathology |
2022;56(3):115-125 |
Neuropathologic features of central nervous system hemangioblastoma |
Neutrophil-lymphocyte ratio |
2023;57(2):88-94 |
Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma |
Next-generation sequencing |
2022;56(4):173-186 |
Lymphoproliferative disorder involving body fluid: diagnostic approaches and roles of ancillary studies |
Non-functioning pituitary adenomas |
2022;56(1):22-31 |
Association of PTTG1 expression with invasiveness of non-functioning pituitary adenomas |
Non-osteogenic |
2022;56(5):270-280 |
Special AT-rich sequence-binding protein 2 (SATB2) in the differential diagnosis of osteogenic and non-osteogenic bone and soft tissue tumors |
Non-small cell lung carcinoma |
2022;56(1):53-56 |
TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma |
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features |
2022;56(6):319-325 |
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: its updated diagnostic criteria, preoperative cytologic diagnoses and impact on the risk of malignancy |
Notch pathway |
2022;56(4):205-211 |
EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome |
Observer variation |
2022;56(6):334-341 |
Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea |
Ocular melanoma |
2022;56(4):187-198 |
Clinicopathologic features and survival outcomes of ocular melanoma: a series of 31 cases from a tertiary university hospital |
ODN2088 |
2022;56(2):81-91 |
Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injury |
Oral cavity carcinoma |
2022;56(3):126-133 |
Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand |
Oropharyngeal carcinoma |
2022;56(3):126-133 |
Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand |
Ossification |
2022;56(5):294-300 |
Heterotopic mesenteric ossification: a report of two cases |
Osteoid |
2022;56(5):270-280 |
Special AT-rich sequence-binding protein 2 (SATB2) in the differential diagnosis of osteogenic and non-osteogenic bone and soft tissue tumors |
Osteosarcoma |
2022;56(5):270-280 |
Special AT-rich sequence-binding protein 2 (SATB2) in the differential diagnosis of osteogenic and non-osteogenic bone and soft tissue tumors |
Overall survival |
2022;56(6):342-353 |
A clinicopathologic and immunohistochemical study of primary and secondary breast angiosarcoma |
2022;56(4):187-198 |
Clinicopathologic features and survival outcomes of ocular melanoma: a series of 31 cases from a tertiary university hospital |
Oxidative phosphorylation |
2023;57(6):305-314 |
Senescent tumor cells in colorectal cancer are characterized by elevated enzymatic activity of complexes 1 and 2 in oxidative phosphorylation |
Pandemic |
2022;56(6):361-369 |
Current status of cytopathology practice in Korea: impact of the coronavirus pandemic on cytopathology practice |
Papanicolaou smear |
2022;56(5):260-269 |
Cytopathologic features of human papillomavirus–independent, gastric-type endocervical adenocarcinoma |
Papanicolaou test |
2022;56(6):354-360 |
Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology: a 25-year single-center study |
Papillary thyroid carcinoma |
2022;56(5):301-308 |
Papillary and medullary thyroid carcinomas coexisting in the same lobe, first suspected based on fine-needle aspiration cytology: a case report |
2022;56(4):199-204 |
Correlation between myoferlin expression and lymph node metastasis in papillary thyroid carcinoma |
papillomavirus |
2022;56(5):289-293 |
Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection |
Paranasal sinus |
2022;56(3):152-156 |
A sinonasal yolk sac tumor in an adult |
Parasites |
2023;57(1):28-42 |
Infections and immunity: associations with obesity and related metabolic disorders |
Pathologists |
2023;57(5):278-283 |
Diagnostic conundrums of schwannomas: two cases highlighting morphological extremes and diagnostic challenges in biopsy specimens of soft tissue tumors |
Pathology |
2023;57(1):43-51 |
Single-cell and spatial sequencing application in pathology |
Pathology report |
2023;57(1):1-27 |
A standardized pathology report for gastric cancer: 2nd edition |
Patient centered care |
2023;57(6):289-304 |
The Asian Thyroid Working Group, from 2017 to 2023 |
PD-L1 |
2022;56(1):32-39 |
Clinicopathologic implication of PD-L1 gene alteration in primary adrenal diffuse large B cell lymphoma |
PD-L1 SP142 |
2022;56(2):73-80 |
Fatty acid synthetase expression in triple-negative breast cancer |
Peutz-Jeghers syndrome |
2023;57(2):128-131 |
Solitary Peutz-Jeghers type harmartomatous polyp in duodenum with gastric foveolar epithelium: a case report |
PI3K-Akt pathway |
2022;56(4):205-211 |
EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome |
Pituitary tumor transforming gene expression |
2022;56(1):22-31 |
Association of PTTG1 expression with invasiveness of non-functioning pituitary adenomas |
Plasma cell myeloma |
2023;57(2):132-137 |
Unusual biclonal IgA plasma cell myeloma with aberrant expression of high-risk immunophenotypes: first report of a new diagnostic and clinical challenge |
Plasmacytoid variant |
2022;56(4):217-224 |
Clinically undetected plasmacytoid urothelial carcinoma of the urinary bladder with non-mass-forming metastases in multiple organs: an autopsy case |
Polo-like kinase 4 |
2022;56(1):40-47 |
Polo-like kinase 4 as a potential predictive biomarker of chemoradioresistance in locally advanced rectal cancer |
Poly(ADP-ribose) polymerase inhibitors |
2023;57(6):323-331 |
BRCA-mutated gastric adenocarcinomas are associated with chromosomal instability and responsiveness to platinum-based chemotherapy |
Polymerase chain reaction |
2022;56(4):173-186 |
Lymphoproliferative disorder involving body fluid: diagnostic approaches and roles of ancillary studies |
Position emission tomography |
2023;57(4):242-245 |
Intrathyroidal metastasis of tonsillar squamous cell carcinoma masquerading as a primary thyroid tumor |
Postmortem examination |
2023;57(2):102-112 |
Postmortem lung and heart examination of COVID-19 patients in a case series from Jordan |
Practice guideline |
2023;57(4):208-216 |
Reevaluating diagnostic categories and associated malignancy risks in thyroid core needle biopsy |
Precision m |
2022;56(6):326-333 |
Biomarker testing of cytology specimens in personalized medicine for lung cancer patients |
Predictive value of tests |
2022;56(6):334-341 |
Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea |
Primary breast angiosarcoma |
2022;56(6):342-353 |
A clinicopathologic and immunohistochemical study of primary and secondary breast angiosarcoma |
Prognosis |
2023;57(5):284-288 |
EWSR1 rearranged primary renal myoepithelial carcinoma: a diagnostic conundrum |
2023;57(4):232-237 |
Loss of aquaporin-1 expression is associated with worse clinical outcomes in clear cell renal cell carcinoma: an immunohistochemical study |
2023;57(2):132-137 |
Unusual biclonal IgA plasma cell myeloma with aberrant expression of high-risk immunophenotypes: first report of a new diagnostic and clinical challenge |
2022;56(3):144-151 |
Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis |
2022;56(1):1-15 |
Follicular lymphoma: updates for pathologists |
Prostate-specific membrane antigen |
2022;56(3):134-143 |
Expression of prostate-specific membrane antigen in the neovasculature of primary tumors and lymph node metastasis of laryngeal squamous cell carcinomas |
Prosthesis |
2023;57(1):75-78 |
Metallic implant-associated lymphoma: ALK-negative anaplastic large cell lymphoma associated with total knee replacement arthroplasty |
protein |
2022;56(5):270-280 |
Special AT-rich sequence-binding protein 2 (SATB2) in the differential diagnosis of osteogenic and non-osteogenic bone and soft tissue tumors |
Proteomics |
2023;57(1):67-74 |
The proteomic landscape shows oncologic relevance in cystitis glandularis |
2022;56(6):309-318 |
The application of high-throughput proteomics in cytopathology |
PTEN |
2023;57(3):178-183 |
Thyroid pathology, a clue to PTEN hamartoma tumor syndrome |
Quality |
2022;56(6):361-369 |
Current status of cytopathology practice in Korea: impact of the coronavirus pandemic on cytopathology practice |
Quality assurance |
2023;57(5):251-264 |
Diagnostic proficiency test using digital cytopathology and comparative assessment of whole slide images of cytologic samples for quality assurance program in Korea |
Quality assurance program |
2022;56(6):370-382 |
Development of quality assurance program for digital pathology by the Korean Society of Pathologists |
Quality control |
2022;56(6):370-382 |
Development of quality assurance program for digital pathology by the Korean Society of Pathologists |
Radiation therapy |
2022;56(1):16-21 |
Clinicopathological differences in radiation-induced organizing hematomas of the brain based on type of radiation treatment and primary lesions |
Radiation-induced organizing hematoma |
2022;56(1):16-21 |
Clinicopathological differences in radiation-induced organizing hematomas of the brain based on type of radiation treatment and primary lesions |
Rap1 pathway |
2022;56(4):205-211 |
EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome |
Recommendations |
2022;56(6):370-382 |
Development of quality assurance program for digital pathology by the Korean Society of Pathologists |
Rectal neoplasms |
2022;56(1):40-47 |
Polo-like kinase 4 as a potential predictive biomarker of chemoradioresistance in locally advanced rectal cancer |
reports |
2022;56(5):294-300 |
Heterotopic mesenteric ossification: a report of two cases |
Residents |
2023;57(5):265-272 |
Establishing molecular pathology curriculum for pathology trainees and continued medical education: a collaborative work from the Molecular Pathology Study Group of the Korean Society of Pathologists |
2023;57(2):95-101 |
Current state of cytopathology residency training: a Korean national survey of pathologists |
Risk of malignancy |
2022;56(6):319-325 |
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: its updated diagnostic criteria, preoperative cytologic diagnoses and impact on the risk of malignancy |
RNA sequencing |
2023;57(1):52-59 |
Perspectives on single-nucleus RNA sequencing in different cell types and tissues |
Salivary duct carcinoma |
2023;57(3):158-165 |
Frequent apocrine changes in pleomorphic adenoma with malignant transformation: a possible pre-malignant step in ductal carcinoma ex pleomorphic adenoma |
Secondary breast angiosarcoma |
2022;56(6):342-353 |
A clinicopathologic and immunohistochemical study of primary and secondary breast angiosarcoma |
Seminoma |
2022;56(1):48-52 |
Chronic lymphocytic leukemia and concurrent seminoma in the same testis |
Sequencing |
2022;56(3):161-166 |
Adrenal hemangioblastoma |
Single-cell analysis |
2023;57(1):52-59 |
Perspectives on single-nucleus RNA sequencing in different cell types and tissues |
Single-cell sequencing |
2023;57(1):43-51 |
Single-cell and spatial sequencing application in pathology |
Skin cancer |
2022;56(2):103-108 |
Recurrent malignant solitary fibrous tumor of the scalp: a case report and literature review |
Small bones |
2022;56(3):157-160 |
Juxtacortical chondromyxoid fibroma in the small bones: two cases with unusual location and a literature review |
Small bowel |
2022;56(5):294-300 |
Heterotopic mesenteric ossification: a report of two cases |
SMARCA4 |
2022;56(1):53-56 |
TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma |
Soft tissue neoplasms |
2023;57(5):278-283 |
Diagnostic conundrums of schwannomas: two cases highlighting morphological extremes and diagnostic challenges in biopsy specimens of soft tissue tumors |
Solitary fibrous tumor |
2022;56(2):103-108 |
Recurrent malignant solitary fibrous tumor of the scalp: a case report and literature review |
Spatial sequencing |
2023;57(1):43-51 |
Single-cell and spatial sequencing application in pathology |
Squamous cell carcinoma |
2023;57(4):242-245 |
Intrathyroidal metastasis of tonsillar squamous cell carcinoma masquerading as a primary thyroid tumor |
2022;56(5):289-293 |
Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection |
Standardization |
2023;57(1):1-27 |
A standardized pathology report for gastric cancer: 2nd edition |
STAT6 |
2022;56(2):103-108 |
Recurrent malignant solitary fibrous tumor of the scalp: a case report and literature review |
Statistics |
2023;57(2):95-101 |
Current state of cytopathology residency training: a Korean national survey of pathologists |
2022;56(6):361-369 |
Current status of cytopathology practice in Korea: impact of the coronavirus pandemic on cytopathology practice |
Stomach |
2022;56(5):294-300 |
Heterotopic mesenteric ossification: a report of two cases |
Stomach neoplasms |
2023;57(1):1-27 |
A standardized pathology report for gastric cancer: 2nd edition |
2022;56(2):63-72 |
Extremely well-differentiated adenocarcinoma of the stomach: diagnostic pitfalls in endoscopic biopsy |
Stricture |
2022;56(5):239-248 |
Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn’s disease: image processing and analysis study |
Surveys |
2023;57(2):95-101 |
Current state of cytopathology residency training: a Korean national survey of pathologists |
2022;56(6):361-369 |
Current status of cytopathology practice in Korea: impact of the coronavirus pandemic on cytopathology practice |
T-cell |
2023;57(2):123-127 |
Unsuspected systemic Epstein-Barr virus–positive T-cell lymphoma of childhood diagnosed at autopsy in a potential homicide case |
Tandem mass spectrometry |
2023;57(1):67-74 |
The proteomic landscape shows oncologic relevance in cystitis glandularis |
Targeted gene sequencing |
2022;56(2):92-96 |
An unusual case of microsatellite instability–high/deficient mismatch repair (MSI-H/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing |
Targeted therapy |
2023;57(2):113-122 |
Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer |
Telocyte |
2022;56(5):239-248 |
Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn’s disease: image processing and analysis study |
Testis |
2022;56(1):48-52 |
Chronic lymphocytic leukemia and concurrent seminoma in the same testis |
Thyroid |
2022;56(6):319-325 |
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: its updated diagnostic criteria, preoperative cytologic diagnoses and impact on the risk of malignancy |
Thyroid neoplasms |
2023;57(6):289-304 |
The Asian Thyroid Working Group, from 2017 to 2023 |
2023;57(4):208-216 |
Reevaluating diagnostic categories and associated malignancy risks in thyroid core needle biopsy |
Thyroid nodule |
2023;57(4):208-216 |
Reevaluating diagnostic categories and associated malignancy risks in thyroid core needle biopsy |
Thyroid pathology |
2023;57(3):178-183 |
Thyroid pathology, a clue to PTEN hamartoma tumor syndrome |
Thyroid transcription factor 1 |
2022;56(1):53-56 |
TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma |
Thyroidectomy |
2023;57(6):289-304 |
The Asian Thyroid Working Group, from 2017 to 2023 |
TLR9 |
2022;56(2):81-91 |
Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injury |
Tonsil |
2023;57(4):242-245 |
Intrathyroidal metastasis of tonsillar squamous cell carcinoma masquerading as a primary thyroid tumor |
Training |
2023;57(5):265-272 |
Establishing molecular pathology curriculum for pathology trainees and continued medical education: a collaborative work from the Molecular Pathology Study Group of the Korean Society of Pathologists |
Transcriptome |
2023;57(1):52-59 |
Perspectives on single-nucleus RNA sequencing in different cell types and tissues |
2023;57(1):43-51 |
Single-cell and spatial sequencing application in pathology |
transitional cell |
2023;57(1):67-74 |
The proteomic landscape shows oncologic relevance in cystitis glandularis |
Treatment |
2022;56(1):1-15 |
Follicular lymphoma: updates for pathologists |
Triple-negative breast neoplasms |
2022;56(2):73-80 |
Fatty acid synthetase expression in triple-negative breast cancer |
Tumor staging |
2022;56(4):199-204 |
Correlation between myoferlin expression and lymph node metastasis in papillary thyroid carcinoma |
Tumor-associated lymphocyte |
2023;57(2):88-94 |
Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma |
Tumor-associated neutrophil |
2023;57(2):88-94 |
Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma |
ulcerative |
2023;57(1):60-66 |
Inflammatory bowel disease–associated intestinal fibrosis |
Unknown primary neoplasms |
2023;57(3):166-177 |
Clinicopathologic characterization of cervical metastasis from an unknown primary tumor: a multicenter study in Korea |
Urinary bladder |
2022;56(4):217-224 |
Clinically undetected plasmacytoid urothelial carcinoma of the urinary bladder with non-mass-forming metastases in multiple organs: an autopsy case |
Urinary bladder neoplasms |
2023;57(1):67-74 |
The proteomic landscape shows oncologic relevance in cystitis glandularis |
Urothelial carcinoma |
2022;56(4):217-224 |
Clinically undetected plasmacytoid urothelial carcinoma of the urinary bladder with non-mass-forming metastases in multiple organs: an autopsy case |
Uterine cervical neoplasms |
2022;56(6):354-360 |
Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology: a 25-year single-center study |
Uterine cervix |
2023;57(3):139-146 |
Trouble-makers in cytologic interpretation of the uterine cervix |
Uveal melanoma |
2023;57(4):238-241 |
Metastatic choroidal melanoma in the breast: a case report and review of the literature |
2022;56(4):187-198 |
Clinicopathologic features and survival outcomes of ocular melanoma: a series of 31 cases from a tertiary university hospital |
V600E |
2022;56(6):334-341 |
Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea |
Vascular endothelial growth factor |
2023;57(2):113-122 |
Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer |
Vascular neoplasm |
2023;57(5):273-277 |
Hepatic small vessel neoplasm: not totally benign, not yet malignant |
Virology |
2023;57(2):102-112 |
Postmortem lung and heart examination of COVID-19 patients in a case series from Jordan |
von Hippel-Lindau disease |
2022;56(3):161-166 |
Adrenal hemangioblastoma |
2022;56(3):115-125 |
Neuropathologic features of central nervous system hemangioblastoma |
Whole slide image |
2022;56(6):370-382 |
Development of quality assurance program for digital pathology by the Korean Society of Pathologists |
Whole-slide image |
2023;57(5):251-264 |
Diagnostic proficiency test using digital cytopathology and comparative assessment of whole slide images of cytologic samples for quality assurance program in Korea |
Whole-slide scanner |
2023;57(5):251-264 |
Diagnostic proficiency test using digital cytopathology and comparative assessment of whole slide images of cytologic samples for quality assurance program in Korea |
Wnt signaling pathway |
2023;57(6):315-322 |
Elevated expression of Axin2 in intestinal metaplasia and gastric cancers |
Yolk sac tumor |
2022;56(3):152-156 |
A sinonasal yolk sac tumor in an adult |
β-catenin |
2023;57(6):315-322 |
Elevated expression of Axin2 in intestinal metaplasia and gastric cancers |